The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.

The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans.

This in-site reader presents the headline and limited excerpt supplied through the publisher’s feed. The original reporting remains with MarketWatch.